CD19 and T-cell non-Hodgkin lymphoma: We used two NK cell lines, SNK6 and NK92MI, for these studies; SNK6 cells are nasal NK/T cell lymphoma cells, are positive for CD56, and negative for CD3, CD4, CD8, CD19, and TCR.